Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group-Reference-Cited by-同舟云学术

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group

Published:2022-01 Issue:1 Volume:28 Page:1-5
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Diallo Alpha,Trøseid Marius,Simensen Victoria Charlotte,Boston Anaïs,Demotes Jacques,Olsen Inge Christoffer,Chung Florence,Paiva José Artur,Hites Maya,Ader Florence,Arribas Jose Ramon,Baratt-Due Andreas,Melien Øyvind,Tacconelli Evelina,Staub Thèrèse,Greil Richard,Tsiodras Sotirios,Briel Matthias,Esperou Hélène,Mentré France,Eustace Joe,Saillard Juliette,Delmas Christelle,LeMestre Soizic,Dumousseaux Marina,Costagliola Dominique,Røttingen John-Arne,Yazdanpanah Yazdan

Funder

European Commission

French Government Ministry of Social Affairs Health and Womens Rights

Ministere de l'Enseignement superieur de la Recherche et de l'Innovation

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference5 articles.

1. COVID-19 platform trial delivers;Mullard;Nat Rev Drug Discov,2020

2. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults;Ader;BMJ Open,2020

3. Master protocols to study multiple therapies, multiple diseases, or both;Woodcock;N Engl J Med,2017